Cargando…
Dexametasona en COVID-19: ¿un medicamento para todos?
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U. and SEMICYUC.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119443/ https://www.ncbi.nlm.nih.gov/pubmed/35598952 http://dx.doi.org/10.1016/j.medine.2021.03.003 |
| _version_ | 1784710700856246272 |
|---|---|
| author | Zangrillo, A. Landoni, G. Monti, G. Yavorovskiy, A.G. Baiardo Redaelli, M. |
| author_facet | Zangrillo, A. Landoni, G. Monti, G. Yavorovskiy, A.G. Baiardo Redaelli, M. |
| author_sort | Zangrillo, A. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9119443 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier España, S.L.U. and SEMICYUC. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91194432022-05-20 Dexametasona en COVID-19: ¿un medicamento para todos? Zangrillo, A. Landoni, G. Monti, G. Yavorovskiy, A.G. Baiardo Redaelli, M. Med Intensiva (Engl Ed) Carta al Editor Elsevier España, S.L.U. and SEMICYUC. 2022-05 2022-05-19 /pmc/articles/PMC9119443/ /pubmed/35598952 http://dx.doi.org/10.1016/j.medine.2021.03.003 Text en © 2021 Elsevier España, S.L.U. and SEMICYUC. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Carta al Editor Zangrillo, A. Landoni, G. Monti, G. Yavorovskiy, A.G. Baiardo Redaelli, M. Dexametasona en COVID-19: ¿un medicamento para todos? |
| title | Dexametasona en COVID-19: ¿un medicamento para todos? |
| title_full | Dexametasona en COVID-19: ¿un medicamento para todos? |
| title_fullStr | Dexametasona en COVID-19: ¿un medicamento para todos? |
| title_full_unstemmed | Dexametasona en COVID-19: ¿un medicamento para todos? |
| title_short | Dexametasona en COVID-19: ¿un medicamento para todos? |
| title_sort | dexametasona en covid-19: ¿un medicamento para todos? |
| topic | Carta al Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119443/ https://www.ncbi.nlm.nih.gov/pubmed/35598952 http://dx.doi.org/10.1016/j.medine.2021.03.003 |
| work_keys_str_mv | AT zangrilloa dexametasonaencovid19unmedicamentoparatodos AT landonig dexametasonaencovid19unmedicamentoparatodos AT montig dexametasonaencovid19unmedicamentoparatodos AT yavorovskiyag dexametasonaencovid19unmedicamentoparatodos AT baiardoredaellim dexametasonaencovid19unmedicamentoparatodos |